1. Home
  2. HHS vs XCUR Comparison

HHS vs XCUR Comparison

Compare HHS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$3.19

Market Cap

26.9M

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$6.35

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHS
XCUR
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
26.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HHS
XCUR
Price
$3.19
$6.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1K
1.8M
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$166,841,000.00
N/A
Revenue This Year
$6.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$3.10
52 Week High
$5.92
$22.99

Technical Indicators

Market Signals
Indicator
HHS
XCUR
Relative Strength Index (RSI) 49.36 58.13
Support Level $2.75 $5.15
Resistance Level $3.23 $6.89
Average True Range (ATR) 0.25 1.02
MACD -0.02 0.16
Stochastic Oscillator 38.60 45.85

Price Performance

Historical Comparison
HHS
XCUR

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: